Thomas Brodowicz

Thomas Brodowicz is an Austrian doctor and university professor. He is an associate professor at the Medical University of Vienna in oncology .

Life

After graduating from high school , Brodowicz studied medicine and received his doctorate in 1995 . He successfully completed his training as a specialist in internal medicine in 2001. On June 19, 2002 he completed his habilitation. He also completed a degree in hospital management. He is also a member of the Advisory Board of the Sarcoma Conference .

His research focus is on clinical studies on soft tissue sarcoma and the so-called gastrointestinal stromal tumor (GIST) . In 2001 he received the Fellinger Prize from the Austrian Cancer Aid in Lower Austria. He is a member of the American Society of Clinical Oncology .

Publications

• Pazopanib in Primary Cardiac Angiosarcoma of the Right Atrium: A Case Report.
• Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2 / neu- positive advanced breast cancer: results of the CECOG LaVie trial.
• Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer.
• The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.

Web links

• Profile Brodowicz 'on the website of the Medical University of Vienna
• List of publications (117 titles)

Individual evidence

1. ↑ the Advisory Board members of the Sarcoma Conference (as of 2016)  ( page no longer available , search in web archives )  Info: The link was automatically marked as defective. Please check the link according to the instructions and then remove this notice.  
2. ↑ Dr. Thomas Brodowicz. Austrian Cancer Aid Lower Austria, accessed on August 2, 2016 .